Sutimlimab Uses, Dosage, Side Effects and more
Sutimlimab is under investigation in clinical trial NCT03347422 (A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion (Cadenza Study)).
| Trade Name | Sutimlimab |
| Availability | Prescription only |
| Generic | Sutimlimab |
| Sutimlimab Other Names | Sutimlimab |
| Related Drugs | Enjaymo |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
